Plasma resistin level in obstructive sleep apnea hypopnea syndrome

National Medical Journal of China

Volumn 88, Issue 34, 2008, Pages 2399-2402

  Li, Min ^a   He, Xiao Guang ^b   Qu, Shen Hong ^b   Zhan, Hong Mou ^b   Yang, Yi Bing ^b   Xu, Xin ^b   Si, Yong Feng ^b  

^a PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

^b NONE

Author keywords

Obesity; Resistin; Sleep apnea, obstructive

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; RESISTIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; OBESITY; OXYGEN SATURATION; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SLEEP APNEA SYNDROME; WAIST HIP RATIO;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; RESISTIN; SLEEP APNEA, OBSTRUCTIVE; WAIST-HIP RATIO;

EID: 56849087328     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature, 2001, 409:307-312.
2. Chinese source.
3. WHO/IASO/IOTF. The Asia-Pacific perspective: redefining obesity and its treatment Melbourne: Health Communications, 2000.
4. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord, 1998, 22:1164-1171.
5. Holcomb IN, Kabakoff RC, Chan B, et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J, 2000, 19: 4046-4055.
6. Steppan CM, Brown EJ, Wright CM, et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A, 2001, 98:502-506.
7. Chinese source.
8. Mortimore IL, Whittle AT, Douglas NJ. Comparison of nose and face mask CPAP therapy for sleep apnoea. Thorax, 1998, 53: 290-292.
9. Shinohara E, Kihara S, Yamashita S. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med, 1997, 241:11-18.
10. Harsch IA, Koebnick C, Wallaschofski H, et al. Resistin levels in patients with obstructive sleep apnoea syndrome - the link to subclinical inflammation? Med Sci Monit, 2004, 10:CR510-515.
11. Fasshauer M, Klein J, Neumann S, et al. Isoproterenol inhibits resistin gene expression through a G (S) -protein-coupled pathway in 3T3-L1 adipocytes. FEBS Lett, 2001, 500:60-63.
12. Liu H, Liu J, Xiong S, et al. The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome. J Tongji Med Univ, 2000, 20:200-202.
13. Asensio C, Cettour-Rose P, Theander-Carrillo C, et al. Changes in glycemia by leptin administration or high-fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis. Endocrinology, 2004, 145: 2206-2213.
14. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab, 2000, 85:1151-1158.